RK

Raghunandan Kesarilal Kothari

Active Director Director DIN 09384226
DIN 09384226 First appointment Nov 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Raghunandan Kesarilal Kothari

Data last updated:

Raghunandan Kesarilal Kothari is a Director at Pinkcity Retina Medical Research Foundation (since 2021). The company operates in Healthcare.

DIN 09384226
Primary Designation Director
Industry Healthcare
First Appointment 01 Nov 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Nov 20212021Active

Board colleagues of Raghunandan Kesarilal Kothari

NameDINCompanyDesignation
Pratibha Kothari09384227Pinkcity Retina Medical Research FoundationDirector

Directorship timeline

Open interactive timeline →
Pinkcity Retina Medical Research Foundation
Premium access

Shareholding and investment profile for Raghunandan Kesarilal Kothari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raghunandan Kesarilal Kothari

Raghunandan Kesarilal Kothari currently holds 1 directorship: Pinkcity Retina Medical Research Foundation (Director, since 01 Nov 2021).

Raghunandan Kesarilal Kothari was first appointed on 01 Nov 2021 as Director at Pinkcity Retina Medical Research Foundation.

The current boards of Raghunandan Kesarilal Kothari's companies include Pratibha Kothari (Pinkcity Retina Medical Research Foundation).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available